Page breadcrumb nav

VAERS Report 2156576

Case Report Section

Détails du rapport Vaer

Âge: N/A

Genre: Female

Région : Outside US

Patient décédé?
Non
Renseignements sur les vaccins

Nom: COVID19 (COVID19 (PFIZER-BIONTECH))

Type : Coronavirus 2019 vaccine

Fabricant: PFIZER

Lot: unknown


Date de réception du rapport
2022-03-04
Date à laquelle le formulaire est complèté
Date de vaccination
Date d’apparition
0
Nombre de jours (date d’apparition – date de vaccination)
0
Description de l’événement indésirable

heavy menstrual bleeding; long term menstruation issues, such as excessive periods, heavy bleeding and frequent pain; clot blood; pain; swelling; feeling of warmth; vein exposure; this is a spontaneous report received from a contactable reporter (consumer or other non hcp) from the regulatory agency (ra). the reporter is the patient. regulatory number: gb-mhra-vac-202202112246533790-dqpzw (ra). other case identifier: gb-mhra-adr 26596186 (ra). a 28-year-old female patient received bnt162b2 (pfizer covid-19 vaccine) (batch/lot number: unknown) as dose 1, single for covid-19 immunisation. the patient had no relevant medical history. the patient's concomitant medications were not reported. the following information was reported: thrombosis (medically significant) with onset 22may2021, outcome "recovered with sequelae", described as "clot blood"; pain (medically significant), outcome "recovered", described as "pain"; swelling (medically significant), outcome "recovered", described as "swelling"; feeling hot (medically significant), outcome "recovered", described as "feeling of warmth"; vein disorder (medically significant), outcome "unknown", described as "vein exposure"; heavy menstrual bleeding (medically significant), outcome "unknown", described as "heavy menstrual bleeding"; menstrual disorder (medically significant), outcome "unknown", described as "long term menstruation issues, such as excessive periods, heavy bleeding and frequent pain". therapeutic measures were taken as a result of thrombosis, pain, swelling, feeling hot, vein disorder and included treatment with aspirin. clinical course: the patient experienced major blood clot in back of left leg after receiving 1st dose. experienced pain, swelling, heat, vein exposure for approximately 4 days. the patient was advised to take aspirin and monitor the situation. the patient also experienced long term menstruation issues, such as excessive periods, heavy bleeding and frequent pain. "the patient felt that the reaction occurred as a result of a mistake made in the administration of the vaccine." no follow-up attempts are possible; information about lot/batch number cannot be obtained. no further information is expected

Données de laboratoire
na
Liste des symptômes
heavy menstrual bleeding feeling hot pain menstrual disorder thrombosis swelling vein disorder
Patient décédé?
Non
Date de décès
N/A
Anomalie congénitale
false
Vaccin administré par :
Other
Vaccin acheté par :
Inconnu
Visite d’un patient à l’urgence?
Non
Patient hospitalisé?
Non
Séjour à l’hôpital
Non
Nombre de jours à l’hôpital
Non spécifié
Invalidité permanente?
Non
Allergies:
na
Maladie actuelle
na